Sort
78,016 grants matching “breast cancer”
Integrated Microdevice to Capture and Detect Circulating Tumor Cells
$586,735Richard James Cote · University Of Miami School Of Medicine · R33 · FY2010 · CA
Expectancy and Chemotherapy-Induced Nausea
$586,719Joseph A Roscoe · University Of Rochester · R01 · FY2016 · AT
Computer-Aided Diagnosis of Pulmonary Embolism
$586,687Jianming Liang · Arizona State University-Tempe Campus · R01 · FY2019 · HL
Computational and experimental methods for scalable identification of oncogenic non-coding regions
$586,639Ekta Khurana · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · CA
Investigating Environmental Risk Factors for Breast Cancer Using Adductomics
$586,581William E Funk · Northwestern University At Chicago · R01 · FY2021 · ES
Acquisition of a Beckman-Coulter Optima AUC Analytical Ultracentrifuge for the University of Montana
$586,559Borries Demeler · University Of Montana · S10 · FY2024 · OD
Inflammation, Macrophage Differentiation, and Cancer
$586,559Zheng-Gang Liu · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Therapy for Metastatic breast cancer based on micro RNA silencing
$586,520Zdravka O. Medarova · Massachusetts General Hospital · R01 · FY2020 · CA
Human Studies of Diet and Nutrition
$586,511Christian Abnet · Division Of Cancer Epidemiology And Genetics · ZIA · FY2024 · CA
Retrospective NCI Phantom-Monte Carlo Dosimetry for Late Effects in Wilms Tumor
$586,471John Andrew Kalapurakal · Northwestern University At Chicago · R01 · FY2018 · CA
Characterization of Cancer Stem Cells
$586,471William Farrar · Basic Sciences · Z01 · FY2007 · CA
Modeling the Impact of Targeted Therapy Based on Breast Cancer Subtypes
$586,465Laura J Esserman · University Of California, San Francisco · U01 · FY2014 · CA
Investigating the Molecular Determinants Driving Response and Resistance to HDAC6 Targeted Therapy in Breast Cancer
$586,431Jose M Silva · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · CA
Community-based HIT Tools for Cancer Screening and Health Insurance Promotion
$586,430Jennifer E Devoe · Oregon Health & Science University · R01 · FY2018 · CA
Statistical Methods in Disease Risk Assessment and Prediction
$586,401Shanshan Zhao · National Institute Of Environmental Health Sciences · ZIA · FY2021 · ES
The rodent eye as a non-invasive window for understanding cancer nanotherapeutics
$586,386Kit S Lam · University Of California At Davis · U01 · FY2018 · CA
The rodent eye as a non-invasive window for understanding cancer nanotherapeutics
$586,386Kit S Lam · University Of California At Davis · U01 · FY2017 · CA
The rodent eye as a non-invasive window for understanding cancer nanotherapeutics
$586,386Kit S Lam · University Of California At Davis · U01 · FY2016 · CA
Retinoic Acid Induced Lymphangiogenesis for Post-Surgical Lymphedema
$586,382Alex K. Wong · Rutgers Biomedical And Health Sciences · R01 · FY2025 · HL
Program Leaders
$586,358Robert B. Diasio · Mayo Clinic Rochester · P30 · FY2016 · CA
Program Leaders
$586,335Robert B. Diasio · Mayo Clinic Rochester · P30 · FY2016 · CA
Estrogen receptor fusions genes as drivers of endocrine resistance in breast cancer
$586,301Adrian Vincent Lee · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · CA
Collagen folding and Interactions: from basic principles to bone disorders
$586,290Sergey Leikin · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · Z01 · FY2008 · HD
Self-Testing Options in the era of Primary HPV screening for cervical cancer: the STEP trial
$586,218Beverly Beth Green · Kaiser Foundation Research Institute · R01 · FY2022 · CA
EVALUATING THE GENETIC, HORMONAL, AND EXOGENOUS FACTORS AFFECTING SOMATIC COPY NUMBER VARIATION IN BREAST CANCER
$586,212Brigham & Womens Hospital Inc · · FY2015 · Department of Defense